Hernández Sánchez, María2023-06-222023-06-222022-05-272673-839210.3390/encyclopedia2020061https://hdl.handle.net/20.500.14352/72090Genome-editing systems such as Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 technology have uncovered new opportunities to model diseases such as chronic lymphocytic leukemia. CRISPR/Cas9 is an important means of advancing functional studies of Chronic Lymphocytic Leukemia (CLL) through the incorporation, elimination and modification of somatic mutations in CLL models.engAtribución 3.0 Españahttps://creativecommons.org/licenses/by/3.0/es/journal articlehttps://doi.org/10.3390/encyclopedia2020061https://www.mdpi.com/2673-8392/2/2/61open accessleukemiaCRISPR/Cas9editingOncologíaGenéticaBioquímica (Farmacia)3201.01 Oncología2409 Genética